Phillip Phan

Phillip Phan, PhD

Alonzo and Virginia Decker Professor of Strategy and Entrepreneurship
Academic AreaManagement & Organization
Academic AreaInnovation & Entrepreneurship
Academic AreaHealth
Areas of InterestHealth care innovation commercialization, national innovation policy, artificial intelligence, patient safety and quality

Phillip H. Phan, Ph.D., is the Alonzo and Virginia Decker Professor at the Johns Hopkins Carey Business School and holds a joint appointment as a Professor in the Johns Hopkins Medicine Division of Geriatric Medicine and Gerontology in the Department of Medicine. He is also the Robert Bosch Policy Fellow at the American Academy in Berlin.   

His academic and professional work focuses on technological innovation with an emphasis on patient safety, quality, and biomedicine. He has published more than 300 peer-reviewed research articles and is the author/editor of 13 scholarly books. He is the Deputy Editor of the International Journal for Quality in Health Care, the Academic Editor of Medicine®, and the Editor of the Journal of Technology Transfer. He is a grant reviewer for the National Institutes of Health and the National Science Foundation.    

He is the Director of Strategy for the Johns Hopkins Armstrong Institute for Patient Safety and Quality, a co-Principal Investigator and Director of the Networking and Mentoring Core of the Johns Hopkins Artificial Intelligence Collaboratory for Aging Research, and co-Principal Investigator and Director of the Johns Hopkins Innovation for Substance Use Disorder program. Additionally, he is the co-founder of P4Microbiome Inc., an antimicrobial peptide-based biotech startup.

Education

  • Ph. D, University of Washington - Seattle
  • BBA, Hospitality Management School of Travel Industry Management, University of Hawaii - Manoa

Research

Selected Publications

  •  Schoenborn NL, Chae K, Massare J, Ashida S, Abadir P, Arbaje AI, Unberath M, Phan P, Cudjoe TKM. (2025) Perspectives on AI and Novel Technologies Among Older Adults, Clinicians, Payers, Investors, and Developers. JAMA Network Open. 8(4):e253316. ^p
  • Lee, H., Cullen, B., Athey, A., Holingue, C., Kaufman, M. R., Nestadt, P., Samuels, J., Vannorsdall, T., Phan, P. (2025). Representative national survey on drug use during the COVID-19 stay-at-home order in the USA. BMJ Open, 15(3), e086141. ^p
  • Eng PC, Lee SH, Der Teo AE, Lim DST, Tan LLY, Tan GK, Tai ES, Phan P, Khoo CM. (2025) Postnatal glycaemic outcomes in women with high-risk gestational diabetes: Identifying key predictors for early intervention. Diabetes Obes Metab. 27(2): 845-855. doi:10.1111/dom.16085 ^p 12.
  • Bundele, A, Lim, HW, Mukhopadhyay, A, Phan, P, Sumner, J (2024) Divergent views on prescription adherence: A qualitative comparison of perspectives from the patient, pharmacist, and physician triad, European Journal of Internal Medicine, 129: 146 – 148 ^p
  • Long, V, Chen Z, Du RC, Chan YH, Yik WY, Oon HH, Thng S, Qasrina NBIL, Tan C, Chandran NS, Valderas JM, Phan P, Choi E (2023) Understanding Discordant Perceptions of Disease Severity Between Physicians and Patients with Eczema and Psoriasis using Structured Equation Modeling. JAMA Dermatology. 159 (8), 811-819 ^p
  • Long, V, Lau XMN, Ng CXY, Phan PH, Choi CEE (2023) Discordance in perception of disease severity between patient and physicians. European Journal of Internal Medicine, 109:138-140 ^p
  • Choi, CEE, Heng LW, Tan WYL, Phan PH, Chandran NS (2022) Factors Influencing Willingness to Pay and Show Images with Teledermatology during the COVID-19 pandemic, Journal of the American Academy of Dermatology, 87(1): e19-e21 ^p
  • Reina Ortiz, M, Grunauer M, Gutierrez E, Izurieta R, Macis M, Phan P, Rosas C, Teran E (2022) Financial incentives, not behavioral nudges, led to optimized HIV testing among pregnant women in a high burden urban population in Ecuador, American Journal of Tropical Medicine & Hygiene, 106(6): 1703-1710

Teaching

Current

  • Entrepreneurial Ventures
  • Innovation for Humanity

Previous

  • Design Lab
  • Commercializing Discoveries
  • Research and Policy Seminars in Health
  • Social Innovation and Business Sustainability
  • Corporate Strategy
  • Innovation for Humanity
  • Discovery to Market
  • Networked Organizations

Honors and Distinctions

  • SmartState® Center for Innovation + Commercialization, University of South Carolina, Advisory Panel
  • Haniel-Stiftungsgastprofessur, Wirtschaftswissenschaftliche Fakultät, Humbolt-Universität zu Berlin (2004)
  • Associate Editor, Journal of Business Venturing (2001-2015)
  • Associate Editor, Journal of Financial Stability (2003-2019)
  • Robert Bosch Foundation Public Policy Fellow, The American Academy in Berlin (2007)
  • Tommie Goh Distinguished Visiting Professor, Singapore Management University (2008)
  • Associate Editor, Journal of Technology Transfer (2011-)
  • Associate Editor, Journal of Family Business Strategy (2014-2020)
  • Editor-in-Chief, Academy of Management Perspectives (2014-)
  • Academic Editor, Medicine® (health services research) (2014-)
  • STaRs Visiting Professor, University of Bergamo, Italy (2019)

Impact and Engagement

Business

  • Director and Principal Investigator, Johns Hopkins Innovation for Substance Use Disorder Program, Johns Hopkins Medicine, and Johns Hopkins Carey Business School
  • Director, Networking and Mentoring Core, Johns Hopkins Artificial Intelligence Technology Collaboratory for Aging Research, Johns Hopkins Malone Center for Engineering in Healthcare and Johns Hopkins Medicine
  • Co-founder of:
    • P4 Microbiome Inc., developer of antimicrobials for the gastrointestinal tract
    • Pistevo LLC, developer of AI solutions to improve medical billing accuracy
    • FKP Consulting LLC, consultancy devoted to vascular and interventional radiology.

Community

  • Mentor, A-Level Capital
  • Editor, eix.org (Entrepreneurship and Innovation Exchange)

In the Media

Jump to top of page